Biotechnology stocks with a focus on the US market
ISIN: AT0000A0XYP0  

Top holdings (2020/06/30)
ISIN Name Currency %FA
US75886F1075 REGENERON PHARMAC.DL-,001 USD 7.06%
US8036071004 SAREPTA THERAP. DL-,0001 USD 6.64%
US3755581036 GILEAD SCIENCES DL-,001 USD 5.84%
US92532F1003 VERTEX PHARMAC. DL-,01 USD 5.62%
US09061G1013 BIOMARIN PHAR. DL-,001 USD 4.58%
US4523271090 ILLUMINA INC. DL-,01 USD 4.54%
US09062X1037 BIOGEN INC. DL -,0005 USD 3.63%
US0311621009 AMGEN INC. DL-,0001 USD 3.33%
US8125781026 SEATTLE GENETICS DL-,001 USD 3.07%
US02043Q1076 ALNYLAM PHARMACE.DL-,0001 USD 2.97%
Holdings by country (2020/06/30)
92.75% United States of America
1.80% Hong Kong
1.50% Netherlands
Percentage holdings by sector (2020/06/30)
82.77% Biotechnology
7.74% Pharmaceuticals
7.73% Life Sciences Tools & Services
1.75% Health Care Services
Holdings by currency (2020/06/30)
97.95% USD
2.05% EUR
Full names of open Mutual funds are given in the fund statutes (prospectuses). Pursuant to rules applicable to collective investment, the manager informs that neither the current or expected performance will guarantee the future performance. Investment in investment certificates contains the risk that the current value of amount invested and yields on the amount will fluctuate; thus return on the amount invested is not guaranteed. All information provided herein is of informative nature only and it should not substitute the statute (prospectus) or give its overall summary. Before using this website/information for investment, you should consult consultants of Česká spořitelna. If any yield is mentioned in the reference material, you should always bear in mind that past yields will not guarantee future yields, that any investment is subject to the risk of value fluctuations and change of exchange rates, and that return on the amount invested or profit margin cannot be guaranteed.